3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Melanoma
19
Neuroblastoma
16
Leukemia
15
Prostatic Neoplasms
14
Lymphoma
12
Multiple Myeloma
10
Breast Neoplasms
10
Lymphoma, Non-Hodgkin
8
Leukemia, Myeloid, Acute
8
Leukemia, Lymphocytic, Chronic, B-Cell
8
Glioblastoma
8
Neoplasm Metastasis
6
Myelodysplastic Syndromes
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Fallopian Tube Neoplasms
6
Neoplasms
5
Hodgkin Disease
5
Carcinoma, Non-Small-Cell Lung
5
Uveal Melanoma
4
Recurrence
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Kidney Neoplasms
4
Glioma
4
Carcinoma, Renal Cell
4
Carcinoma, Ovarian Epithelial
4
Breast Neoplasms, Male
4
Ovarian Neoplasms
3
Neoplasms, Plasma Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Interventions
Granulocyte-Macrophage Colony-Stimulating Factor
1
Diphtheria-Tetanus Vaccine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Xanthomatosis, Cerebrotendinous
×
Granulocyte-Macrophage Colony-Stimulating Factor
×
Clear all
NCT03396575
2025-10-29
BRAVO
University of Florida
Phase 1
Terminated
11 enrolled